Preparation of mesoporous silica nanocarriers targeting glucose-6-phosphate isomerase inhibition and application in the treatment of rheumatoid arthritis

Mesoporous silica nanoparticles combined with AKR1C3 siRNA inhibited the growth of castration-resistant prostate cancer by suppressing androgen synthesis in vitro and in vivo

(2021) Junyu Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Rheumatoid Arthritis

(2021) John J. Cush   MEDICAL CLINICS OF NORTH AMERICA

The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application

(2021) Jun Wu   Journal of Personalized Medicine

Mesoporous silica nanoparticles for pulmonary drug delivery

(2021) Alba García-Fernández et al.   ADVANCED DRUG DELIVERY REVIEWS

The regulation of macrophage polarization by hypoxia-PADI4 coordination in Rheumatoid arthritis

(2021) Yu Cheng et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy

(2020) Yazhe Wang et al.   ACS Applied Materials & Interfaces

Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis

(2020) Jing Xu et al.   CHINESE MEDICAL JOURNAL

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

(2020) Ai-Ming Yu et al.   PHARMACOLOGICAL REVIEWS

Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer

(2019) Dnyaneshwar Kalyane et al.   Materials Science & Engineering C-Materials for Biological Applications

siRNA therapeutics: a clinical reality

(2019) Phei Er Saw et al.   Science China-Life Sciences

The contribution of inflammation and bone destruction to pain in arthritis – a study in murine glucose‐6‐phosphate isomerase (G6PI)‐induced arthritis

(2019) Matthias Ebbinghaus et al.   Arthritis & Rheumatology

Journey of siRNA: Clinical Developments and Targeted Delivery

(2018) Rahul R. Nikam et al.   Nucleic Acid Therapeutics

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery

(2018) Anna Slita et al.   Asian Journal of Pharmaceutical Sciences

Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances

(2018) Reema Narayan et al.   Pharmaceutics

Pathogenetic insights from the treatment of rheumatoid arthritis

(2017) Iain B McInnes et al.   LANCET

Future therapeutic targets in rheumatoid arthritis?

(2017) Tommy Tsang Cheung et al.   Seminars in Immunopathology

Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis

(2017) Ying Lu et al.   Scientific Reports

Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review

(2015) Jaleh Varshosaz et al.   CURRENT PHARMACEUTICAL DESIGN

Nanocarriers for cancer-targeted drug delivery

(2015) Preeti Kumari et al.   JOURNAL OF DRUG TARGETING

Mesoporous silica nanoparticles in drug delivery and biomedical applications

(2015) Ying Wang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis

(2015) Ming Zong et al.   ARTHRITIS RESEARCH & THERAPY

Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis

(2010) Lie Ying Fan et al.   CLINICA CHIMICA ACTA

Rheumatoid arthritis

(2010) David L Scott et al.   LANCET

Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice

(2009) Lisa Bruns et al.   ARTHRITIS RESEARCH & THERAPY